Arietis is developing first-in-class small molecule antibiotics to kill drug resistant bacterial pathogens and treat infections with a high unmet clinical need.

Arietis is located at the Bio Square Discovery and Innovation Center on Boston University's Medical Campus. Arietis was founded on technologies for discovering antimicrobials developed by Professor Kim Lewis at Northeastern University.

Founded in 2008, Arietis bridges an important gap in antimicrobial drug discovery and technology development. Arietis has forged productive alliances and partnerships within the biotechnology community as we advance our capacity to develop effective drug products.

Arietis is developing first-in-class small molecule antibiotics to treat drug resistant bacterial pathogens and infections with a high unmet clinical need. Our lead antibiotics cause bacterial cells to self-digest through activation of the ClpP protease.

Arietis’s platform screening technology has allowed us to identify a number of excellent potent and specific leads for further development. Similarly there is a great need for new antifungal agents. The primary targets for drug development here are biofilms and “persister” cells.

LOCATION Arietis is located at 650 Albany St on the Boston University Medical School Campus. The parking garage is located at 710 Albany St.

If you would like further information about Arietis, please use this form to contact us: Name * First Name Last Name Email Address * Subject * Message *

Although the Arietis approach is novel, the antimicrobial development path is well-defined and straightforward, with animal models extremely predictive of clinical outcome, making this a very attractive therapeutic space.

Arietis is located at 650 Albany St on the Boston University Medical School Campus. The parking garage is located at 710 Albany St.